Citigroup’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-79,500
Closed -$6.35M – 5958
2024
Q3
$6.35M Buy
79,500
+41,700
+110% +$3.13M ﹤0.01% 1653
2024
Q2
$2.71M Sell
37,800
-19,200
-34% -$1.41M ﹤0.01% 2095
2024
Q1
$4.01M Buy
+57,000
New +$4.08M ﹤0.01% 1880

Other funds holding TECH

Citigroup's TECH Position: Q3 2026 in Review

Citigroup increased its Bio-Techne (TECH) stake by 295% in Q3 2026, buying an estimated $94.7M and bringing the position to 1,760,388 shares worth $128M. The position accounts for 0.04% of the portfolio, ranked #414.

Citigroup first reported a position in TECH in Q2 2013 and has held it in 54 quarters since. 586 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Citigroup held 1,760,388 shares of Bio-Techne worth $128M as of Q3 2026.
  • Citigroup bought 1,315,243 Bio-Techne shares in Q3 2026, an estimated $94.7M.
  • Bio-Techne made up 0.04% of Citigroup's portfolio in Q3 2026, its #414 holding.
  • Citigroup first reported a position in Bio-Techne in Q2 2013 and has held it in 54 quarters since.
  • 586 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.